Radiation-Induced Myonecrosis Presenting as a Subcutaneous Mass After Combined Modality Therapy for Non-small Cell Lung Cancer Vamsidhar Velcheti, MD,

Slides:

Advertisements

Similar presentations

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Advertisements

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD

Pulmonary Benign Metastasizing Leiomyoma Following Hysterectomy: A Clinicopathologic Correlation Adidam Venkata Chalapathi Rao, MD, Joyce Wilson, MBcHB,

PUBLISH ONLY Journal of Thoracic Oncology

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Subroto Paul, MD, Michael Kurtz, BS, Steven J. Mentzer, MD

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non– Small Cell Lung Adenocarcinoma Filippo Gustavo Dall’Olio, MD, Celeste.

Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive Factors Lorinda Simms, MSc, P Stat, Helen Barraclough, MSc, Ramaswamy.

Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,

MET-Mutated NSCLC with Major Response to Crizotinib

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Electronic Updates for JTO Readers

Hedgehog Signaling Pathway and Lung Cancer

Circulating tumor DNA: Solid data from liquid biopsies

Muhammad Umair Khawar, MD, Bhaskar Bhardwaj, MD, Himanshu Bhardwaj, MD

Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer Daniel Morgensztern, MD, Saiama.

Estrogen Receptor (ER) and Epidermal Growth Factor Receptor (EGFR) as Targets for Dual Lung Cancer Therapy: Not Just a Case? Monica Giovannini, MD, Carmen.

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer Peter Goldstraw, MB, FRCS, John J. Crowley, PhD

Hibernoma: 18F FDG PET/CT Imaging

Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP

LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis

Pulmonary Benign Metastasizing Leiomyoma Following Hysterectomy: A Clinicopathologic Correlation Adidam Venkata Chalapathi Rao, MD, Joyce Wilson, MBcHB,

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Vamsidhar Velcheti, MD, Manmeet Ahluwalia, MD

Massive Bronchogenic Cyst

Maria Q. Baggstrom, MD, Saiama N. Waqar, MD, Ananth K

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Clinicopathological Characteristics of Screen-Detected Lung Cancers

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Vamsidhar Velcheti, MD Journal of Thoracic Oncology

The Role of Surgery in the Management of Primary Thymic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Kimihiro Shimizu, MD, PhD, Izumi Takeyoshi,

Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L

Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma

Clive Peedell, BM, MRCP, FRCR, Rachel Dykes, MB, BS

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD

Matthew Reichert, MD, Eric S. Bensadoun, MD

Nivolumab-Induced Granulomatous Inflammation of the Pleura

A Case of Pemetrexed-Induced Acute Lung Injury in Non-small Cell Lung Cancer Hye Ok Kim, MD, Sung Yong Lee, MD, PhD, Jae Jeong Shim, MD, PhD, Kyung Ho.

Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey Daniel Morgensztern, MD, Shean Huey Ng,

Giant Malignant Myxoid Fibrous Histiocytoma of the Chest Wall

Nicholas W. Choong, MD, Robert S. Hellman, MD

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

M. Kusumoto Journal of Thoracic Oncology

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

Genetic Changes in Squamous Cell Lung Cancer: A Review

Bronchioloalveolar Carcinoma Presenting as Chronic Progressive Pulmonary Infiltrates in a Woman with HIV: A Diagnosis Worth Making Todd M. Erickson,

European Lung Cancer Conference (ELCC) 2016 Organisation

Recurrent Primary Synovial Sarcoma of the Chest Wall

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer Judith Elizabeth Carser, MB, BCh, MRCR, Yvonne Jane Summers,

Metastatic Lung Cancer to the Pancreas

Mediastinal Sarcoma with Deviated Tracheal Anatomy

Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD

Pleural Metastases of Malignant Melanoma

Christina S. Baik, MD, MPH, Marc C. Chamberlain, MD, Laura Q. Chow, MD

Annemarie Becker, MD, PhD, Atie van Wijk, RN, Egbert F

David Garfield, MD Journal of Thoracic Oncology

Popcorn in the Lung Journal of Thoracic Oncology

Rigid Bronchoscopic Intervention in Patients with Respiratory Failure Caused by Malignant Central Airway Obstruction Kyeongman Jeon, MD, Hojoong Kim,

A B3 Type-Thymoma in a 7-Year-Old Child with Myasthenia Gravis

A Review of First-Line Treatment for Small-cell Lung Cancer

Mark A. Socinski, MD Journal of Thoracic Oncology

Presentation transcript:

Radiation-Induced Myonecrosis Presenting as a Subcutaneous Mass After Combined Modality Therapy for Non-small Cell Lung Cancer Vamsidhar Velcheti, MD, Eve Gilstrap, RN, Jeffrey Bradley, MD, Ramaswamy Govindan, MD Journal of Thoracic Oncology Volume 2, Issue 9, Pages 875-876 (September 2007) DOI: 10.1097/JTO.0b013e31811f3a91 Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 The dose to the isocenter within the target volume was 7350 cGy. Journal of Thoracic Oncology 2007 2, 875-876DOI: (10.1097/JTO.0b013e31811f3a91) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 A computed tomographic scan of the chest revealed an ill-defined low-attenuation lesion within the left trapezius muscle lying medial to the left scapula at the level of the fifth and sixth ribs without invasion of the underlying ribs or the adjacent scapula grossly. Journal of Thoracic Oncology 2007 2, 875-876DOI: (10.1097/JTO.0b013e31811f3a91) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 A computed tomographic-guided biopsy of the soft tissue mass revealed only benign-appearing epithelial cells with scattered elongated nucleoli, probably representing fibroblasts. There were no features diagnostic for malignancy. A follow-up evaluation 4 months later showed spontaneous resolution of the mass. Journal of Thoracic Oncology 2007 2, 875-876DOI: (10.1097/JTO.0b013e31811f3a91) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions